A detailed history of Groupe La Francaise transactions in Insulet Corp stock. As of the latest transaction made, Groupe La Francaise holds 750 shares of PODD stock, worth $231,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares
750
Previous 1,500 50.0%
Holding current value
$231,840
Previous $411 Million 42.93%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$238.57 - $327.47 $178,927 - $245,602
-750 Reduced 50.0%
750 $235 Million
Q4 2024

Feb 14, 2025

BUY
$227.79 - $275.7 $341,685 - $413,550
1,500 New
1,500 $393 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $21.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Groupe La Francaise Portfolio

Follow Groupe La Francaise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupe La Francaise, based on Form 13F filings with the SEC.

News

Stay updated on Groupe La Francaise with notifications on news.